Leucovorin for autism spectrum disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 5 registered trials.

Also followed for narrower conditions: Asperger Syndrome, Autistic Disorder

Why this status

  1. 21 Jul 2016: Trial registered, NCT02839915
  2. 15 Feb 2018: Trial started, NCT03771560
  3. 11 Dec 2018: Trial registered, NCT03771560
  4. 13 Aug 2020: Trial started, NCT02839915
  5. 1 Oct 2020: Trial started, NCT05013164
  6. 19 Aug 2021: Trial registered, NCT05013164
  7. 19 May 2025: Trial started, NCT07630506
  8. 5 Jun 2026: Trial registered, NCT07630506

The trials

NCT02551380: Folinic Acid in Children With Autism Spectrum Disorders

State
State not given
Phase
Phase 2
People
40 planned
Started
Oct 2015
Primary completion
Jan 2018
Arms
Treated
Results
None posted
  1. 16 Sep 2015: Trial registered

NCT02839915: Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder

State
Under way
Phase
Phase 2
People
56 taking part
Started
13 Aug 2020
Primary completion
15 Apr 2024
Arms
Folinic Acid
Results
None posted
  1. 21 Jul 2016: Trial registered
  2. 13 Aug 2020: Trial started

NCT03771560: Folinic Acid in Autism

State
Completed
Phase
Phase 2 and Phase 3
People
18 taking part
Started
15 Feb 2018
Primary completion
30 Jun 2018
Arms
Open-label
Results
Posted on the registry
  1. 15 Feb 2018: Trial started
  2. 30 Jun 2018: Trial completed
  3. 11 Dec 2018: Trial registered
  4. 3 Dec 2019: Trial results posted

NCT05013164: Role of Folinic Acid in Improving the Adaptive Skills and Language Impairment in Children With Autism Spectrum Disorder

State
Completed
Phase
Phase 2
People
44 taking part
Started
1 Oct 2020
Primary completion
30 Mar 2021
Arms
Folinic Acid + Behavioral Therapy
Results
None posted
  1. 1 Oct 2020: Trial started
  2. 30 Mar 2021: Trial completed
  3. 19 Aug 2021: Trial registered

NCT07630506: Folinic Acid as a Treatment for Autism Spectrum Disorder in Children

State
Under way
Phase
Phase 2
People
184 planned
Started
19 May 2025
Primary completion
30 Jun 2027
Arms
Folinic Acid
Results
None posted
  1. 19 May 2025: Trial started
  2. 5 Jun 2026: Trial registered

How the status changed

  1. 16 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Folinoral, Folinic Acid.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.